Phytomedicines for menopause

Drugs of the Future

Volumn 32, Issue 10, 2007, Pages 897-905

  Doyle, Brian J ^a   Mahady, Gail B ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 PRENYLNARINGENIN; ANGELICA SINENSIS EXTRACT; ANTIDEPRESSANT AGENT; CIMICIFUGA RACEMOSA EXTRACT; CLONIDINE; DIOSCOREA VILLOSA EXTRACT; ESTROGEN; GESTAGEN; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; GLYCINE MAX EXTRACT; GLYCYRRHIZA EXTRACT; HUMULUS LUPULUS EXTRACT; HYPERICUM PERFORATUM EXTRACT; ISOFLAVONE DERIVATIVE; KAVA EXTRACT; NARINGENIN; PLACEBO; PLANT EXTRACT; RED CLOVER EXTRACT; SEROTONIN UPTAKE INHIBITOR; TAMOXIFEN; UNCLASSIFIED DRUG; VALERIAN; VITEX AGNUS CASTUS EXTRACT;

ABSENCE OF SIDE EFFECTS; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONGESTIVE HEART FAILURE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG STRUCTURE; ENDOMETRIUM HYPERPLASIA; FOOD AND DRUG ADMINISTRATION; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; LIVER TOXICITY; MENOPAUSAL SYNDROME; MONOTHERAPY; NONHUMAN; PALLIATIVE THERAPY; PHYTOTHERAPY; REVIEW; WOMEN'S HEALTH;

EID: 36749102539     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2007.032.10.1133260     Document Type: Review

References (98)

1. Cass, I., Runowicz, C.D. Nonhormonal alternatives to treating menopausal symptoms. Am J Manag Care 1998, 4(5): 732-8.
2. Taylor, M. Alternatives to conventional hormone replacement therapy. Compr Ther 1997, 23(8): 514-32.
3. Mahady, G.B., Fong, H.H.S., Farnsworth, N.R. Rhizoma Cimicifugae Racemosae. In: WHO Monographs on Selected Medicinal Plants, Vol. II. World Health Organization, Geneva, 2002.
4. Mahady, G.B., Huang, Y., Doyle, B., Locklear, T.D. Black cohosh (Actaea racemosa) for the mitigation of menopausal symptoms: Recent developments in clinical safety and efficacy. J Womens Health 2006, 2(5): 773-83.
5. Alexander, I.M., Andrist, L.C. In: Women's Gynecologic Health. Schuiling, K.D., Likis, F.E. (Eds.). Jones and Bartlett Publishers, Sudbury, 2006, 253-4.
6. Hill, K. The demography of menopause. Maturitas 1996, 23(2): 113-27.
7. Locklear, T.D., Doyle, B.J., Caceres, A., Perez, A., Mahady, G.B. Menopause: A universal female experience, lessons from Central America. Curr Women's Health Rev 2007, In press.
8. Pace, D.T. Menopause: Studying the research. Nurse Pract 2006, 31(8): 17-23.
9. Wijma, K., Melin, A., Nedstrand, E., Hammar, M. Treatment of menopausal symptoms with applied relaxation: A pilot study. J Behav Ther Exp Psychiatry 1997, 28(4): 251-61.
10. Mayo, J.L. A natural approach to menopause. Appl Nutr Sci Rep 1999, 5: 1-8.
11. Grady, D., Rubin, S.M., Petitti, D.B. et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992, 117(12): 1016-37.
12. Barrett-Connor, E., Kritz-Silverstein, D. Estrogen replacement therapy and cognitive function in older women. JAMA - J Am Med Assoc 1993, 269(20): 2637-41.
13. Houmard, B.S., Battaglia, D.E., Seifer, D.B. In: The Physiologic Basis of Gynecology and Obstetrics. Seifer, D.B., Samuels, P., Kniss, D.A. (Eds.). Lippincott Williams and Wilkins, Philadelphia, 2001, 185-90.
14. Power, M.L., Schulkin, J., Rossouw, J.E. Evolving practice patterns and attitudes toward hormone therapy of obstetrician-gynecologists. Menopause 2007, 14(1): 20-8.
15. Morelli, V., Naquin, C. Alternative therapies for traditional disease states: Menopause. Am Fam Physician 2002, 66(1): 129-34.
16. Rossouw, J.E., Anderson, G.L., Prentice, R.L. et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results rrom the Women's Health Initiative randomized controlled trial. JAMA - J Am Med Assoc 2002, 288(3): 321-33.
17. Nelson, H.D., Vesco, K.K., Haney, E. et al. Nonhormonal therapies for menopausal hot flashes: Systematic review and metaanalysis. JAMA - J Am Med Assoc 2006, 295(17): 2057-71.
18. Kronenberg, F., Fugh-Berman, A. Complementary and alternative medicine for menopausal symptoms: A review of randomized, controlled trials. Ann Intern Med 2002, 137(10): 805-13.
19. Mahady, G.B. Black cohosh (Actaea/Cimicifuga racemosa): Review of the clinical data for safety and efficacy in menopausal symptoms. Treat Endocrinol 2005, 4(3): 177-84.
20. Frei-Kleiner, S., Schaffner, W., Rahlfs, V.W., Bodmer, Ch., Birkhauser, M. Cimicifuga racemosa dried ethanolic extract in menopausal disorders: A double-blind placebo-controlled clinical trial. Maturitas 2005, 51(4): 397-404.
21. Munoz, G.H., Pluchine, S. Cimicifuga racemosa for the treatment of hot flashes in women surviving breast cancer. Maturitas 2003, 44(Suppl. 1): S59-65.
22. Nappi, R.E., Malavasi, B., Brundu, B., Facchinetti, F. Efficacy of Cimicifuga racemosa on climacteric complaints: A randomized study versus low-dose transdermal estradiol. Gynecol Endocrinol 2005, 20(1): 30-5.
23. Newton, K.M., Reed, S.D., LaCroix, A.Z., Grothaus, L.C., Ehrlich, K., Guiltinan, J. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: A randomized trial. Ann Intern Med 2006, 145(12): 869-79.
24. Osmers, R., Friede, M., Liske, E., Schnitker, J., Freudenstein, J., Henneicke-von Zepelin, H.H. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet Gynecol 2005, 105(5, Pt. 1): 1074-83.
25. Pockaj, B.A., Loprinzi, C.L., Sloan, J.A. et al. Pilot evaluation of black cohosh for the treatment of hot flashes in women. Cancer Invest 2004, 22(4): 515-21.
26. Uebelhack, R., Blohmer, J.U., Graubaum, H.J., Busch, R., Gruenwald, J., Wernecke, K.D. Black cohosh and St. John's wort for climacteric complaints: A randomized trial. Obstet Gynecol 2005, 107(2, Pt. 1): 247-55.
27. Verhoeven, M.O., van der Mooren, M.J., van de Weijer, P.H., Verdegem, P.J., van der Burgt, L.M., Kenemans, P. Effect of a combination of isoflavones and Actaea racemosa Linnaeus on climacteric symptoms in healthy symptomatic perimenopausal women: A 12-week randomized, placebo-controlled, double-blind study. Menopause 2005, 12(4): 412-20.
28. Vermes, G., Banhidy, F., Acs, N. The effects of remifemin on subjective symptoms of menopause. Adv Ther 2005, 22(2): 148-54.
29. Wuttke, W., Seidlova-Wuttke, D., Gorkow, C. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: Effects on menopause symptoms and bone markers. Maturitas 2003, 44(Suppl. 1): S67-77.
30. Pockaj, B.A., Gallagher, J.G., Loprinzi, C.L. et al. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1. J Clin Oncol 2006, 24(18): 2836-41.
31. Mahady, G.B. Is black cohosh estrogenic? Nutr Rev 2003, 61: 183-6.
32. Low Dog, T. Menopause: A review of botanical dietary supplements. Am J Med 2005, 118(12, Suppl.): 98-108.
33. Burdette, J.E., Liu, J., Chen, S.N. et al. Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. J Agric Food Chem 2003, 51(19): 5661-70.
34. Kruse, S.O., Löhning, A., Pauli, G.F., Winterhoff, H., Nahrstedt, A. Fukiic and piscidic acid esters from the rhizome of Cimicifuga racemosa and the in vitro estrogenic activity of fukinolic acid. Planta Med 1999, 65(8): 763-4.
35. Struck, D., Tegtmeier, M., Harnischfeger, G. Flavones in extracts of Cimicifuga racemosa. Planta Med 1997, 63(3): 289.
36. McCoy, J., Kelly, W. Survey of Cimicifuga racemosa for phytoestrogens flavonoids. 212th ACS Natl Meet (Aug 25-29, Orlando) 1996.
37. Minciullo, P.L., Saija, A., Patafi, M., Marotta, G., Ferlazzo, B., Gangemi, S. Muscle damage induced by black cohosh (Cimicifuga racemosa). Phytomedicine 2006,13(1-2): 115-8.
38. Australian Therapeutic Goods Administration, http://www.tga.gov.au/cm/ blkcohosh.htm, March 1, 2006.
39. National Center for Complementary and Alternative Medicine, National Institutes of Health. Workshop on the safety of black cohosh in clinical studies - Meeting summary. ncam.nih.gov Web site, accessed October 3.
40. Lotthammer, K.H., Grunert, E., Elghamry, M.I. Fertility disorders in a cattle herd fed with corn- and clover-grass-silage containing estrogens. Berl Munch Tierarztl Wochenschr 1970, 83(18): 353-7.
41. Kallela, K., Heinonen, K., Saloniemi, H. Plant oestrogens; the cause of decreased fertility in cows. A case report. Nord Vet Med 1984, 36(3-4): 124-9.
42. Farnsworth, N.R. (Ed.). NAPRALERT database. Chicago, University of Illinois at Chicago (an online database available directly through the University of Illinois at Chicago or through the Scientific and Technical Network [STN] of Chemical Abstracts Services), June 30, 2005.
43. Ernst, E., Pittler, M.H., Wider, B., Boddy, K. (Eds.) The Desktop Guide to Complementary and Alternative Medicine, 2nd Ed. Mosby, London, 2006.
44. Newall, C.A., Anderson, L.A., Phillipson, J.D. Herbal Medicines, a Guide for Healthcare Professionals. The Pharmaceutical Press, London, 1996.
45. Lin, L.Z., He, X.G., Lindenmaier, M., Yang, J., Cleary, M., Qiu, S.X., Cordell, G.A. LC-ESI-MS study of the flavonoid glycoside malonates of red clover (Trifolium pratense). J Agric Food Chem 2000, 48(2): 354-65.
46. He, X.G., Lin, L.Z., Lian, L.Z. Analysis of flavonoids from red clover by liquid chromatography-electrospray mass spectrometry. J Chromatogr 1996, 755: 127-32.
47. Dornstauder, E., Jisa, E., Unterrieder, I., Krenn, L., Kubelka, W., Jungbauer, A. Estrogenic activity of two standardized red clover extracts (Menoflavon) intended for large scale use in hormone replacement therapy. J Steroid Biochem Mol Biol 2001, 78(1): 67-75.
48. Liu, J., Burdette, J.E., Xu, H. et al. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem 2002, 49(5): 2472-9.
49. Burdette, J.E., Liu, J., Lantvit, D. et al. Trifolium pratense (red clover) exhibits estrogenic effects in vivo in ovariectomized Sprague-Dawley rats. J Nutr 2002, 132(1): 27-30.
50. Coon, J.T., Pittler, M.H., Ernst, E. Trifolium pratense isoflavones in the treatment of menopausal hot flushes: A systematic review and meta-analysis. Phytomedicine 2007, 14(2-3): 153-9.
51. van de Weijer, P.H.M., Barentsen, R. Isoflavones from red clover (Promensil®) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas 2002, 42(3): 187-93.
52. Jeri, A.R. The use of an isoflavone supplement to relieve hot flushes. Female Patient 2002, 27: 35-7.
53. Baber, R.J., Templeman, C., Morton, T., Kelly, G.E., West, L. Randomised placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric 1999, 2(2): 85-92.
54. Knight, D.C., Howes, J.B., Eden, J.A. The effect of Promensil™, an isoflavone extract, on menopausal symptoms. Climacteric 1999, 2(2): 79-84.
55. Tice, J.A., Ettinger, B., Ensrud, K., Wallace, R., Blackwell, T., Cummings, S.R. Phytoestrogen supplements for the treatment of hot flashes: The Isoflavone Clover Extract (ICE) Study: A randomized controlled trial. JAMA - J Am Med Assoc 2003, 290(2): 207-14.
56. Krebs, E.E., Ensrud, K.E., MacDonald, R., Wilt, T.J. Phytoestrogens for treatment of menopausal symptoms: A systematic review. Obstet Gynecol 2004, 104(4): 824-36.
57. Samman, S., Lyons, W.P.M., Chan, G.S., Smith, S.J., Petocz, P. The effect of supplementation with isoflavones on plasma lipids and oxidisability of low density lipoprotein in premenopausal women. Atherosclerosis 1999, 147(2): 277-83.
58. Howes, J.B., Sullivan, D., Lai, N. et al. The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of postmenopausal women with mild to moderate hypercholesterolemia. Atherosclerosis 2000, 152(1): 143-7.
59. Nestel, P.J., Pomeroy, S., Kay, S., Komesaroff, P., Behrsing, J., Cameron, J.D., West, L. Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J Clin Endocrinol Metab 1999, 84(3): 895-8; erratum in J Clin Endocrinol Metab 1999, 84(10): 3647.
60. Clifton-Bligh, P.B., Baber, R.J., Fulcher, G.R., Nery, M.L., Moreton, T. The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism. Menopause 2001, 8(4): 259-65.
61. Schult, T.M., Ensrud, K.E., Blackwell, T., Ettinger, B., Wallace, R., Tice, J.A. Effect of isoflavones on lipids and bone turnover markers in menopausal women. Maturitas 2004, 48(3): 209-18.
62. Atkinson, C. et al. The effects of isoflavone phytoestrogens on bone: Preliminary results from a large randomised controlled trial. 82nd Annu Meet Endocrine Soc (June 21-24, Toronto) 2000, Abst 196.
63. Bennetts, H.W., Underwood, E.J., Shier, F.L. A specific breeding problem of sheep on subterrranean clover pastures in Western Australia. Aust Vet J 1946, 22: 2-12.
64. Piersen, C.E., Booth, N.L., Sun, Y. et al. Chemical and biological characterization and clinical evaluation of botanical dietary supplements: A phase I red clover extract as a model. Curr Med Chem 2004, 11(11): 1361-74.
65. Booth, N.L., Nikolic, D., van Breemen, R.B., Geller, S.E., Banuvar, S., Shulman, L.P., Farnsworth, N.R. Confusion regarding anticoagulant coumarins in dietary supplements. Clin Pharmacol Ther 2004, 76(6): 511-6.
66. Adlercreutz, H., Hämäläinen, E., Gorbach, S., Goldin, B. Dietary phyto-oestrogens and the menopause in Japan. Lancet 1992, 339: 1233-8.
67. Nagata, C., Takatsuka, N., Inaba, S., Kawakami, N., Shimizu, H. Effect of soymilk consumption on serum estrogen concentrations in premenopausal Japanese women. J Natl Cancer Inst 1998, 90(23): 1830-5.
68. Albertazzi, P., Pansini, F., Bonaccorsi, G., Zanotti, L., Forini, E., De Aloysio, D. The effect of dietary soy supplementation on hot flushes. Obstet Gynecol 1998, 91(1): 6-11.
69. St. Germain, A., Peterson, C.T., Robinson, J.G., Alekel, D.L. Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment. Menopause 2001, 8(1): 17-26.
70. Upmalis, D.H., Lobo, R., Bradley, L., Warren, M., Cone, F.L., Lamia, C.A. Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: A multicenter, double-blind, randomized, placebo-controlled study. Menopause 2000, 7(4): 236-42.
71. Unter, V., Casini, M.L., Costabile, L. et al. Endometrial effects of long-term treatment with phytoestrogens: A randomized, double-blind, placebo-controlled study. Fertil Steril 2004, 82(1): 145-8.
72. Balk, J.L., Whiteside, D.A., Naus, G., DeFerrari, E., Roberts, J.M. A pilot study of the effects of phytoestrogen supplementation on postmenopausal endometrium. J Soc Gynecol Investig 2002, 9(4): 238-42.
73. Crisafulli, A., Marini, H., Bitto, A. et al. Effects of genistein on hot flushes in early postmenopausal women: A randomized, double-blind EPT- and placebo-controlled study. Menopause 2004, 11(4): 400-4.
74. Duncan, A.M., Underhill, K.E.W., Xu, X. et al. Modest hormonal effects of soy isoflavones in postmenopausal women. J Clin Endocrinol Metab 1999, 84(10): 3479-84; erratum in J Clin Endocrinol Metab 2000, 85(1): 448.
75. Hale, G.E., Hughes, C.L., Robboy, S.J., Agarwal, S.K., Bievre, M. A double blind placebo controlled trial on the effect of red clover isoflavones on the endometrium. Menopause 2001, 8(5): 338-46.
76. Nikander, E., Rutanen, E.M., Nieminen, P., Wahlstrom, T., Ylikorkala, O., Tiitinen, A. Lack of effect of isoflavonoids on the vagina and endometrium in postmenopausal women. Fertil Steril 2005, 83(1): 137-42.
77. Sammartino, A., Di Carlo, C., Mandato, V.D., Bifulco, G., Di Stefano, M., Nappi, C. Effects of genistein on the endometrium: Ultrasonographic evaluation. Gynecol Endocrinol 2003, 17(1): 45-9.
78. Scambia, G., Mango, D., Signorile, P.G., Anselmi, R.A., Palena, C., Gallo, D. Clinical effects of a standardized soy extract in postmenopausal women: A pilot study. Menopause 2000, 7: 105-11.
79. Murray, M.J., Meyer, W.R., Lessey, M. et al. Soy protein isolate with isoflavones does not prevent estradiol-induced endometrial hyperplasia in postmenopausal women. Menopause 2003, 10(5): 456-64.
80. Chen, W.F., Wong, M.S. Genistein enhances insulin-like growth factor signaling pathway in human breast cancer (MCF-7) cells. J Clin Endocrinol Metab 2004, 89(5): 2351-9.
81. Barnes, S. The chemopreventive properties of soy isoflavonoids in animal models of breast cancer. Breast Cancer Res Treat 1997, 46(2-3): 169-79.
82. Foth, D., Cline, J.M. Effects of mammalian and plant estrogens on mammary glands and uteri of macaques. Am J Clin Nutr 1998, 68(Suppl. 6): 1413S-7S.
83. Kayisli, U.A., Aksu, C.A., Berkkanoglu, M. et al. Estrogenicity of isoflavones on human endometrial stromal and glandular cells. J Clin Endocrinol Metab 2002, 87(12): 5539-44.
84. Lee, Y.B., Lee, H.J., Kim, K.S., Lee, J.Y., Nam, S.Y., Cheon, S.H., Sohn, H.S. Evaluation of the preventive effect of isoflavone extract on bone loss in ovariectomized rats. Biosci Biotechnol Biochem 2004, 68(5): 1040-5.
85. Picherit, C., Coxam, V., Bennetau-Pelissero, C., Kati-Coulibaly, S., Davicco, M.J., Lebecque, P., Barlet, J.P. Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats. J Nutr 2000, 130(7): 1675-81.
86. Santell, R.C., Chang, Y.C., Nair, M.G., Helferich, W.G. Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats. J Nutr 1997, 127(2): 263-9.
87. St. Clair, R.W. Estrogens and atherosclerosis: Phytoestrogens and selective estrogen receptor modulators. Curr Opin Lipidol 1998, 9(5): 457-63.
88. Tansey, G., Hughes, C.L., Cline, J.M., Krummer, A., Walmer, D.K., Schmoltzer, S. Effects of dietary soybean estrogens on the reproductive tract in female rats. Proc Soc Exp Biol Med 1998, 217(3): 340-4.
89. Whitehead, S.A., Lacey, M. Protein tyrosine kinase activity of lavendustin A and the phytoestrogen genistein on progesterone synthesis in cultured rat ovarian cells. Fertil Steril 2000, 73(3): 613-9.
90. German Pharmacopoeia, the monograph Lupuli strobulus describes indications for hops as a sedative and sleep promoting aid, see: Hop Strobile - Lupuli flos, in: European Pharmacopoeia, 3rd Ed. (Suppl.). Council of Europe, Strasbourg, 2000, 795.
91. Milligan, S.R., Kalita, J.C., Heyerick, A., Rong, H., De Cooman, L., De Keukeleire, D. Identification of a potent phytoestrogen in hops (Humulus lupulus L.) and beer. J Clin Endocrinol Metab 1999, 84(6): 2249-52.
92. Milligan, S.R., Kalita, J.C., Pocock, V. et al. The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoids. J Clin Endocrinol Metab 2000, 85(12): 4912-5.
93. Milligan, S., Kalita, J., Pocock, V., Heyerick, A., De Cooman, L., Rong, H., De Keukeleire, D. Oestrogenic activity of the hop phyto-oestrogen, 8-prenylnaringenin. Reproduction 2002, 123(2): 235-42.
94. Goetz, P. Traitement des bouffées de chaleur par insuffisance ovarienne par l'extrait de houblon (Humulus lupulus). Rev Phytothér Prat 1990, 4: 13-5.
95. Heyerick, A., Vervarcke, S., Depypere, H., Bracke, M., De Keukeleire, D. A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas 2006, 54(2): 164-75.
96. Geller, S.E., Studee, L. Contemporary alternatives to plant estrogens for menopause. Maturitas 2006, 55(1): S3-13.
97. Ulbricht, C., Basch, E., Boon, H. et al. Safety review of kava (Piper methysticum) by the Natural Standard Research Collaboration. Expert Opin Drug Saf 2005, 4(4): 779-94.
98. Whitten, D.L., Myers, S.P., Hawrelak, J.A., Wohlmuth, H. The effect of St John's wort extracts on CYP3A: A systematic review of prospective clinical trials. Br J Clin Pharmacol 2006, 62(5): 512-26.